Evidence map›Paper›PMID 42158590›Full record

ArticleBMJ neurology open2026

Amyloid-β-related angiitis presenting as leptomeningitis.

Pablo Gómez-Porro, Beatriz De La Puente, Lorena Fernández, Beatriz Brea, Ana Ramírez, Joaquin Carneado, Raquel González

Abstract read
In one paragraph

Article in BMJ neurology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pablo Gómez-PorroNeurology, Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Madrid, Spain.ORCID https://orcid.org/0000-0003-1964-7739
Beatriz De La PuenteNeurology, Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Madrid, Spain.ORCID https://orcid.org/0009-0007-0331-9905
Lorena FernándezNeurology, Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Madrid, Spain.
Beatriz BreaNeurology, Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Madrid, Spain.
Ana RamírezNeurology, Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Madrid, Spain.
Joaquin CarneadoNeurology, Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Madrid, Spain.
Raquel GonzálezNeurology, Puerta de Hierro University Hospital of Majadahonda, Majadahonda, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inflammatory cerebral amyloid angiopathy (ICAA) is an atypical presentation of cerebral amyloid angiopathy (CAA), caused by an autoimmune reaction against cerebral beta-amyloid deposits. ICAA can be divided into two different entities: cerebral amyloid angiopathy-related inflammation (CAA-RI) and amyloid beta-related angiitis (ABRA). Case presentation: We report a histologically confirmed case of ABRA in which initial radiological findings were relatively subtle, resulting in a substantial diagnostic challenge. In this context, supportive cerebrospinal fluid findings, including elevated kappa free light chain index, suggested an inflammatory aetiology with leptomeningitis. A brain biopsy was ultimately required to establish a definitive diagnosis. Conclusions: As illustrated in this case, ABRA may present with subtle radiological findings. We highlight the importance of including ABRA in the differential diagnosis of leptomeningitis. We introduce the concept that the kappa index, although currently underused, may represent a biomarker of potential interest and clinical utility in the diagnostic work-up of this group of disorders.

Indexed as

AMYLOIDCEREBROVASCULAR DISEASEVASCULITIS

Identifiers

PMID42158590
PMCPMC13182461

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.